NeuBase Therapeutics, Inc.

  • ABOUT US
  • TECHNOLOGY
  • PIPELINE
  • PATIENTS
  • PARTNERING
  • INVESTORS
  • CONTACT US

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • In The News
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • In The News
  • IR Calendar
  • Email Alerts
Dec 21, 2022 8:00am EST

NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2022

Oct 21, 2022 8:00am EDT

NeuBase Therapeutics Announces Gene Editing Research Agreement with Global Healthcare Company

Oct 14, 2022 4:05pm EDT

NeuBase Therapeutics Announces Strategic Restructuring Focused on Advancing Its Platform in Gene Editing

Sep 22, 2022 4:05pm EDT

NeuBase to Participate at Chardan’s 6th Annual Genetic Medicines Conference

Aug 11, 2022 8:00am EDT

NeuBase Therapeutics Reports Business Update and Financial Results for the Third Quarter of Fiscal Year 2022

Jun 29, 2022 8:01am EDT

NeuBase Therapeutics Announces Promotion of Dr. William Mann to President and COO

Jun 01, 2022 7:00am EDT

NeuBase to Participate at the Jefferies Healthcare Conference

May 17, 2022 7:00am EDT

NeuBase Presents New Preclinical Data at ASGCT 2022 for Its DM1 Program Demonstrating Wide Tissue Distribution and Supporting a Differentiated Whole-Body Treatment Solution

May 12, 2022 5:00pm EDT

NeuBase Therapeutics Reports Business Update and Financial Results for the Second Quarter of Fiscal Year 2022

May 02, 2022 4:30pm EDT

NeuBase Therapeutics Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) 2022 Annual Meeting

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Neubase

NeuBase Therapeutics, Inc.
350 Technology Drive
Pittsburgh, PA 15219

info@neubasetherapeutics.com

Sign up for news

©2023 NeuBase Therapeutics, Inc. All rights reserved.

Privacy Policy|Terms of Use